Exceptional people – not code or capital – build transformative, category-defining companies.
We back deeply independent thinkers with audacious dreams and relentless determination.
Most importantly, we partner with special founders who have the rare ability to do two really hard things simultaneously:
- anticipate what will move society and culture forward in the future (we call this: “time jumping”, and it’s what makes certain founders “special”), and
- build and lead a transformative, category-defining company, from the outset through to massive scale.
We focus on a company’s long-term impact and invest at any stage from seed to growth rounds. We often work alongside founders at the ideation stage as an inception partner, as well as providing strategic insights and a willing sounding board to founders throughout the entire company lifecycle.
Wormhole Capital is the investment arm of Vivek Garipalli’s family office. While sector-agnostic, we seek business models that inherently propel a positive flywheel effect.
In 1935, Albert Einstein and physicist Nathan Rosen used the theory of general relativity to propose the existence of wormholes. These tunnel-like passages (also known as Einstein-Rosen “bridges”) connect two different points in space-time, theoretically creating a shortcut that reduces travel time and distance through superluminal (faster-than-light) motion. In other words: time travel.
Gourmet organic candy that serves a higher purpose [Seed]
Simple, tech-enabled health plans for the modern employee [Seed]
Deploy a secure, HIPAA-compliant app from day one [Seed]
Bringing you a better glass of wine, no matter where you are [Seed]
Technology company committed to improving health equity for seniors [Inception]
Document automation and data extraction using AI [Series A]
Medical imaging company leveraging data science and biomagnetism in the fight against cardiovascular disease [Series A]
Vertical SaaS platform for small business owners in the beauty and wellness space [Seed]
Mental healthcare system provider that helps patients connect with therapists and submit insurance claims online [Seed]
Health and technology company providing fertility, gynaecology, and family-building care [Seed]
Provider of medical equipment ordering software [Growth]
API designed for healthcare innovators that gives access to vital medical data [Series A]
Provides the back-end infrastructure that enables ubiquitous integration of genetics in medicine [Seed]
Values-aligned, membership-based society that is constructing a new metropolis [Seed]
Digital closing platform for real estate and mortgage companies to provide simple, secure homebuying experiences [Series B]
Health insurance company that uses software, data science and telemedicine to make health insurance delightful, affordable and easier to access in Nigeria [Series A]
Digitizing the pharmaceutical supply chain in Africa [Seed]
Machine learning-driven pharma company [Series A]
Operating platform for retailers to capture digital advertising dollars and build customer loyalty [Seed]
Prior to Clover, Vivek co-founded both CarePoint Health and Ensemble Health. CarePoint is a healthcare system that offers acute care and emergency services to a large, historically underserved population in Hudson County, New Jersey. Ensemble is a national healthcare revenue cycle services company. The experience of building these two companies — and seeing firsthand the misalignment between healthcare providers, insurance companies, and most importantly, consumers — ultimately inspired the founding of Clover Health.
With Flatiron Health, Vivek saw the opportunity to leverage technology to help align mission with business model. At Flatiron, he entered as an early investor, and advised on their strategy and business model, including leading the acquisition of its data platform, Altos. He subsequently sat on the board through its sale to Roche in 2018 and currently serves / has served on the boards of Cityblock Health, Clover Health, Doctor Evidence, Flatiron Health, Medically Home, and Thyme Care.
Vivek began his career in finance, holding roles at Credit Suisse First Boston, J.P. Morgan Partners and Blackstone Group.